Summary of the MHRA Good Distribution Practice Symposium 2023
![GDP in Switzerland (GDP 3)](files/eca/userImages/training.img/Z-GDP3-GDP-in-Switzerland-neues-Layout.jpg)
Recommendation
12 September 2024
Basel, Switzerland
Specifics in the Distribution of Medicinal Products (Course in english language!)
Just recently, you could read about the Good Manufacturing and Distribution Practice Symposia 2023, organized by the Medicines and Healthcare products Regulatory Agency (MHRA) on 21 and 22 February 2023. The first day of the conference focused on regulatory developments in the area of Good Distribution Practice (GDP).
A summary of the GDP part was now published on the MHRA Inspectorate blog. The article dated 02 May 2023 was written by Manuela Krasteva. In the introduction, she states that "the event included a variety of topics with a special emphasis on updates on our regulatory position and the MHRA’s role as a sovereign regulator. The theme of the day was largely influenced by the changes following the UK’s departure from the EU."
The blog post goes on, giving a brief summary of the individual contributions. Among the topics presented were the environmental changes and their impact on GDP activities, as well as the role of the so-called Responsible Person (Import), RPi.
To read the full article, please see the MHRA Inspectorate blog "MHRA Good Distribution Practice Symposium 2023".
Related GMP News
16.07.2024Templates for Shortage Prevention and Mitigation Plans issued by EMA
16.07.2024New Measures to Report Medicine Disappearances
16.07.2024GDP Non-Compliance Report for Czech Wholesale Distributor
16.07.2024Checklist for Implementation of GDP Principles - Part 9: Transportation
12.06.2024EU adopts Supply Chain Law - Implications for pharmaceutical Companies